Magna Pharmaceuticals Overview
- Year Founded
-
1990

- Status
-
Private
- Employees
-
14

- Latest Deal Type
-
2ndary - Private
Magna Pharmaceuticals General Information
Description
Operator of a pharmaceutical company intended to offer affordable dietary supplements to add value and optimize overall health. The company helps to lower the risk of health problems such as osteoporosis or arthritis that are safe, effective, and affordable in the form of pills, capsules, powders, gel capsules, tablets, extracts, or liquids, enabling customers to have a little extra nutrient boost.
Contact Information
Website
www.magnaweb.comCorporate Office
- 10801 Electron Drive
- Suite 100
- Louisville, KY 40299
- United States
Corporate Office
- 10801 Electron Drive
- Suite 100
- Louisville, KY 40299
- United States
Magna Pharmaceuticals Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
2. Secondary Transaction - Private | 01-Oct-2022 | Completed | Generating Revenue | |||
1. Seed Round | 29-Apr-2014 | Completed | Generating Revenue |
Magna Pharmaceuticals Comparisons
Industry
Financing
Details
Magna Pharmaceuticals Competitors (4)
One of Magna Pharmaceuticals’s 4 competitors is Pfizer Manufacturing Austria, a Corporation company based in Orth An Der Donau, Austria.
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Pfizer Manufacturing Austria | Corporation | Orth An Der Donau, Austria | ||||
Pfizer Pakistan | Corporation | Karachi, Pakistan | ||||
GlaxoSmithKline Consumer Nigeria | Corporation | Lagos, Nigeria | ||||
Genentech | Formerly VC-backed | South San Francisco, CA |
Magna Pharmaceuticals Patents
Magna Pharmaceuticals Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
US-20110040266-A1 | Anti-insomnia compositions and methods | Inactive | 10-May-2007 | ||
US-20080280947-A1 | Using zolpidem; oral spray for transmucous membrane absorption | Inactive | 10-May-2007 | ||
US-20190083471-A1 | Buccal, polar and non-polar spray containing zolipidem | Inactive | 29-Aug-2002 | ||
US-20200061034-A1 | Buccal, polar and non-polar spray containing zolipidem | Inactive | 29-Aug-2002 | ||
US-20100092403-A1 | Aerosol sprays; fast onset of effect | Active | 01-Oct-1997 | A61K31/437 |
Magna Pharmaceuticals Signals
Magna Pharmaceuticals FAQs
-
When was Magna Pharmaceuticals founded?
Magna Pharmaceuticals was founded in 1990.
-
Where is Magna Pharmaceuticals headquartered?
Magna Pharmaceuticals is headquartered in Louisville, KY.
-
What is the size of Magna Pharmaceuticals?
Magna Pharmaceuticals has 14 total employees.
-
What industry is Magna Pharmaceuticals in?
Magna Pharmaceuticals’s primary industry is Pharmaceuticals.
-
Is Magna Pharmaceuticals a private or public company?
Magna Pharmaceuticals is a Private company.
-
What is Magna Pharmaceuticals’s current revenue?
The current revenue for Magna Pharmaceuticals is
. -
How much funding has Magna Pharmaceuticals raised over time?
Magna Pharmaceuticals has raised $1M.
-
Who are Magna Pharmaceuticals’s competitors?
Pfizer Manufacturing Austria, Pfizer Pakistan, GlaxoSmithKline Consumer Nigeria, and Genentech are competitors of Magna Pharmaceuticals.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »